|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00005267 |
Purpose
To map and identify the major genetic determinants of hypertension and to study possible interactions between genetic and non-genetic factors in defined populations. HyperGEN initially consisted of a nine grant network, which in turn is part of an NHLBI initiative, the Family Blood Pressure Program (FBPP) consisting of four networks.
| Condition |
|
Cardiovascular Diseases Heart Diseases Hypertension |
| MedlinePlus related topics: | Heart Diseases High Blood Pressure |
| Study Type: | Observational |
| Study Design: | Natural History |
| Study Start Date: | September 1995 |
| Estimated Study Completion Date: | August 2008 |
![]() |
Show Detailed Description |
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
No eligibility criteria
Contacts and Locations| Investigator: | Donna Arnett | University of Alabama at Birmingham |
| Investigator: | John Eckfeldt | University of Minnesota |
| Investigator: | R.Curtis Ellison | Boston University |
| Investigator: | Steven Hunt | University of Utah |
| Investigator: | Jean-Marc Lalouel | University of Utah |
| Investigator: | Cora Lewis | University of Alabama at Birmingham |
| Investigator: | Kari North | University of North Carolina |
| Investigator: | James Pankow | University of Minnesota |
| Investigator: | Dabeeru Rao | Washington University School of Medicine |
More Information
| Study ID Numbers: | 1151 |
| First Received: | May 25, 2000 |
| Last Updated: | January 27, 2006 |
| ClinicalTrials.gov Identifier: | NCT00005267 |
| Health Authority: | United States: Federal Government |
|
|